Compare First-Line Meds for Parkinson’s

May 2022

About 60,000 people in the US are diagnosed with Parkinson’s disease each year...and you’ll need to help sort through first-line meds.

Meds don’t slow progression, so consider using a “wait-and-see” approach...starting when symptoms impair function or quality of life.

Tailor med choice based on age, symptom severity, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote